Home/Filings/4/0001689575-25-000013
4//SEC Filing

Stueland Katherine 4

Accession 0001689575-25-000013

CIK 0001818331other

Filed

Oct 30, 8:00 PM ET

Accepted

Oct 31, 4:42 PM ET

Size

11.6 KB

Accession

0001689575-25-000013

Insider Transaction Report

Form 4
Period: 2025-10-29
Stueland Katherine
DirectorChief Executive Officer
Transactions
  • Sale

    Class A Common Stock

    2025-10-29$136.75/sh4$5473,436 total
  • Sale

    Class A Common Stock

    2025-10-29$136.54/sh2,154$294,1073,440 total
  • Exercise/Conversion

    Class A Common Stock

    2025-10-29+3,8745,594 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-10-293,8747,748 total
    Class A Common Stock (3,874 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
  • [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  • [F3]Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 3,436 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 440,665 shares of Class A Common Stock and options to purchase up to an aggregate of 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms.
  • [F4]25% of the total award vested on each of April 29, 2023 and April 29, 2024, and an additional 6.25% of the total award vested or vests thereafter on each quarterly anniversary, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the last tranche scheduled to vest on April 29, 2026. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.

Issuer

GeneDx Holdings Corp.

CIK 0001818331

Entity typeother

Related Parties

1
  • filerCIK 0001689575

Filing Metadata

Form type
4
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 4:42 PM ET
Size
11.6 KB